Attenuated dengue 2 viruses with deletions in capsid protein derived from an infectious full-length cDNA clone

Virus Research

Volumn 126, Issue 1-2, 2007, Pages 226-232

  Zhu, Wuyang ^a   Qin, Chengfeng ^a   Chen, Shuping ^a   Jiang, Tao ^a   Yu, Man ^a   Yu, Xuedong ^a   Qin, Ede ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

Author keywords

Capsid protein; Dengue 2 virus; Infectious full length clone; Mutant virus

Indexed keywords

CAPSID PROTEIN; COMPLEMENTARY DNA; DENGUE VACCINE;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DENGUE VIRUS; GENE DELETION; MOLECULAR CLONING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; RAT; VIRUS ATTENUATION; VIRUS MUTANT;

ANIMALS; BASE SEQUENCE; CAPSID PROTEINS; CELL LINE; CHINA; DENGUE; DENGUE VIRUS; DNA PRIMERS; DNA, COMPLEMENTARY; DNA, VIRAL; HUMANS; MICE; MICE, INBRED BALB C; PHENOTYPE; PLAQUE ASSAY; SEQUENCE DELETION; VIRULENCE;

DENGUE VIRUS; DENGUE VIRUS TYPE 2; MIRIDAE; MUS;

EID: 34248202492     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2007.03.004     Document Type: Article

References (22)

1. Chang G.J. Molecular biology of dengue viruses. In: Gubler D.J., and Kuno G. (Eds). Dengue and Dengue Hemorrhagic Fever (1997), CAB International, New York 175-198
2. Clyde K., and Harris E. RNA secondary structure in the coding region of dengue virus type 2 directs translation start codon selection and is required for viral replication. J. Virol. 80 (2006) 2170-2182
3. Couvelard A., Marianneau P., Bedel C., Drouet M.T., Vachon F., Henin D., and Deubel V. Report of a fatal case of dengue infection with hepatitis: demonstration of dengue antigens in hepatocytes and liver apoptosis. Hum. Pathol. 30 (1999) 1106-1110
4. Durbin A.P., Karron R.A., Sun W., Vaughn D.W., Reynolds M.J., Perreault J.R., Thumar B., Men R., Lai C.J., Elkins W.R., Chanock R.M., Murphy B.R., and Whitehead S.S. Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3′-untranslated region. Am. J. Trap. Med. Hyg. 65 (2001) 405-413
5. Durbin A.P., Whitehead S.S., McArthur J., Perreault J.R., Blaney Jr. J.E., Thumar B., Murphy B.R., and Karron R.A. rDEN4Δ30, a live attenuated dengue virus type 4 vaccine candidate, is safe, immunogenic, and highly infectious in healthy adult volunteers. J. Infect. Dis. 191 (2005) 710-718
6. Gubler D.J. Dengue and dengue hemorrhagic fever: its history and resurgence as a global public health problem. In: Gubler D.J. (Ed). Dengue and Dengue Hemorrhagic Fever (1997), CAB International, New York 1-22
7. Jones C.T., Ma L., Burgner J.W., Groesch T.D., Post C.B., and Kuhn R.J. Flavivirus capsid is a dimeric alpha-helical protein. J. Virol. 77 (2003) 7143-7149
8. Kofler R.M., Heinz F.X., and Mandl C.W. Capsid protein C of tick-borne encephalitis virus tolerates large internal deletions and is a favorable target for attenuation of virulence. J. Virol. 76 (2002) 3534-3543
9. Kofler R.M., Aberle J.H., Stephan W., Allison S.L., Heinz F.X., and Mandl C.W. Mimicking live flavivirus immunization with a noninfectious RNA vaccine. Proc. Natl Acad. Sci. U.S.A. 101 (2004) 1951-1956
10. Kuhn R.J., Zhang W., Rossmann M.G., Pletnev S.V., Corver J., Lenches E., Jones C.T., Mukhopadhyay S., Chipman P.R., Strauss E.G., Baker T.S., and Strauss J.H. Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell 108 (2002) 717-725
11. Lemberg M., and Martoglio B. Requirements for signal peptide peptidase-catalyzed intramembrane proteolysis. Mol. Cell 10 (2002) 735-744
12. Lobigs M., and Lee E. Inefficient signalase cleavage promotes efficient nucleocapsid incorporation into budding flavivirus membranes. J. Virol. 78 (2004) 178-186
13. Ma L.X., Jones C.T., and Groesch T.D. Solution structure of dengue virus capsid protein reveals another fold. Proc. Natl Acad. Sci. U.S.A. 101 (2004) 3414-3419
14. Markoff L., Falgout B., and Chang A. A conserved internal hydrophobic domain mediates the stable membrane integration of the dengue virus capsid protein. Virology 233 (1997) 105-117
15. McLauchlan J. Properties of the hepatitis C virus core protein: a structural protein that modulates cellular processes. J. Virol. Hepat. 7 (2000) 2-14
16. Men R., Bray M., Clark D., Chanock R.M., and Lai C.J. Dengue type 4 virus mutants containing deletions in the 3′ noncoding region of the RNA genome: analysis of viremia pattern and immunogenicity in rhesus monkeys. J. Virol. 70 (1996) 3930-3935
17. Rey F.A., Heinz F.X., Mandl C., Kunz C., and Harrison S.C. The envelope glycoprotein from tick-borne encephalitis virus at 2 Å resolution. Nature 75 (1995) 291-298
18. Rice C.M., Lenches E.M., Eddy S.R., Shin S.J., Sheets R.L., and Strauss J.H. Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution. Science 229 (1985) 726-733
19. Wang S.H., Wan J.S., and Hu S.T. Identification of the homotypic interaction domain of the core protein of dengue virus type 2. J. Gen. Virol. 85 (2004) 2307-2314
20. Whitehead S.S., Falgout B., Hanley K.A., Blaney Jr. J.E., Markoff L., and Murphy B.R. A live, attenuated dengue virus type 1 vaccine candidate with a 30-nucleotide deletion in the 3′ untranslated region is highly attenuated and immunogenic in monkeys. J. Virol. 77 (2003) 1653-1657
21. Yang J.S., Ramanathan M.P., and Muthumani K. Induction of inflammation by West Nile virus capsid through the caspase-9 apoptotic pathway. Emerg. Infect. Dis. 8 (2002) 1379-1384
22. Zhu W.Y., Chen S.P., Qin C.F., Yu M., Jiang T., Deng Y.Q., and Qin E.D. Construction and identification of reverse genetics system of Dengue type 2 virus isolated in China. Chin. Sci. Bull. 51 (2006) 2065-2071